Decision

, 2008 FC 825 (Perindopril*)

Justice Snider - 2008-07-02

Read full decision. Automatically generated summary:

The Plaintiffs (described below and collectively referred to as Servier) manufacture, distribute and sell a drug with the trademark of COVERSYL, used primarily in the treatment of
Since at least 2006, one of the Defendants, Apotex Pharmachem Inc. (Pharmachem), has manufactured a generic version of perindopril erbumine tablets at its facility in Brantford, Ontario, in 2 mg, 4 mg and 8 mg strengths, and tablets containing a combination of perindopril erbumine and indapamide (a diuretic). The products are sold to the other Defendant, Apotex Inc., which company, in turn, sells the 8 mg tablets in Canada and exports all dosages and the combination product to affiliated companies and others abroad.

Decision relates to:

 

Canadian Intellectual Property